European Pharmaceutical Review

AUGUST 3, 2023

With the corrective and preventive action (CAPA) process often a “one-size-fits-all” approach, a whitepaper by the Medical Device Innovation Consortium (MDIC) Case for Quality Collaborative Community (CfQcc) has instead shared a risk-based framework focusing on continuous improvement. These results are included in most recent paper.

Documentation 52

Documentation Process Improvement FDA 52

Omnicell

JANUARY 10, 2023

It has developed a framework that identifies five levels of increasing technological capability and work process improvement spanning nine pharmacy work processes. The Advisory Board has coalesced around the clear vision of a fully autonomous pharmacy.

Medical Schools 52

Medical Schools Process Improvement 52

The Happy PharmD

JANUARY 7, 2025

And please, leave irrelevant information off your resume. Its tempting to add extra details to stand out, but they can actually detract from the important information the hiring manager needs to see. For example, Reduced medication errors by 15% through process improvements is much more impactful than Responsible for medication safety.

Patient Care 52

Patient Care Process Improvement Documentation 52

Impact Pharmaceutical Services

SEPTEMBER 15, 2023

Upstream processing advancements encompass fed-batch processes , improved cell culture media, advanced feeding strategies, and tailored bioreactor control. Downstream optimization targets increased throughput, reduced costs, and improved product quality maintenance.

Documentation 59

Documentation Process Improvement Compounding 59

ISPE

MARCH 29, 2023

9 Among other things, the M4Q(R2) EWG is working toward “organizing product and manufacturing information in a suitable format for easy access, analysis, and knowledge management.” information requests) to fully understand the quality data and its significance in an application.” Currently, it takes time and/or communications (e.g.,

Documentation 52

Documentation Dosage Packaging Communication 52

ISPE

MARCH 29, 2023

9 Among other things, the M4Q(R2) EWG is working toward “organizing product and manufacturing information in a suitable format for easy access, analysis, and knowledge management.” information requests) to fully understand the quality data and its significance in an application.” Currently, it takes time and/or communications (e.g.,

Documentation 52

Documentation Dosage Packaging Communication 52

European Pharmaceutical Review

JANUARY 27, 2025

Key to the success of a product is a concurrent transfer of technology, process information and skills gathered at every step of discovery, development and commercialisation.

Communication 52

Communication Documentation Pharmaceutical Companies Pharmaceutical Companies 52

Viseven

JANUARY 30, 2025

Clear communication Patients want to feel heard and informed. Streamlining processes, improving digital tools, and creating a smooth overall experience are essential steps to keeping patients from looking elsewhere. This allows providers to make well-informed decisions, enhancing both operational efficiency and patient outcomes.

Communication 52

Communication Scheduling Appointments Hospitals Process Improvement 52

ISPE

MARCH 15, 2023

linear) design process is central to successfully attaining such comprehensive sustainability goals and project needs (see Figure 1). linear) design process is central to successfully attaining such comprehensive sustainability goals and project needs (see Figure 1). 7 An integrative (vs. 7 An integrative (vs. Leave this field blank

Packaging 52

Packaging Labelling Health Compliance Process Improvement 52

ISPE

AUGUST 29, 2022

Following approval of an initial marketing application, postapproval changes are needed to ensure adequate supply, mitigate supply risk, expand patient market access, optimize manufacturing processes, improve analytical methods, and comply with new regulatory expectations. Common Technical Document [CTD] sections).

Documentation 52

Documentation FDA Communication Packaging 52

European Pharmaceutical Review

MAY 29, 2023

Recently, the European Medicines Agency (EMA) took the lead in pushing for process improvements using technologies already established in other manufacturing sectors. Continuous manufacturing in the biopharmaceutical industry guarantees high quality and high process efficiency.

Process Improvement 95

Process Improvement Packaging Vaccines FDA 95

ISPE

AUGUST 30, 2022

The International Council for Harmonization of Technical Requirements for Pharmaceuticals for Human Use (ICH) guidelines contain information regarding regulatory requirements for raw materials. The name of each material, where it is used in the process, and information on the quality and control should be provided.

Documentation 52

Documentation FDA Packaging Communication 52

The Nontraditional Pharmacist

APRIL 10, 2025

Retail pharmacy provided experience working with patients and staff from varied perspectives, and insight into process improvement. My traditional roles refined these people and process improvement skills, enabling me to build field hospitals in challenging environments with limited resources. Network broadly.

Detail Orientation 52

Detail Orientation Hospitals Process Improvement Vaccines 52

ISPE

SEPTEMBER 11, 2023

Anticipated Future Developments Manufacturing and information processing technologies will continue to advance, expand, and influence our current ways of working to meet the needs of the evolving medical, biopharmaceutical, and regulatory environment. This can simplify future scale-up and technology transfer.

Health and Personal Care Stores 52

Health and Personal Care Stores Vaccines Packaging Documentation 52

ISPE

SEPTEMBER 10, 2023

In addition to delaying optimization of manufacturing and controls, these types of long delays for approvals discourage continuous process improvements for approved products. Previous publications on this subject provide general information on BoH assessment timelines (e.g., > 24 months).

Documentation 98

Documentation Process Improvement Packaging Pharmaceutical Companies 98

Pharmaceutical Technology

MAY 9, 2023

For Jamaels, whose track record in managing complex operations and delivering process improvements spans GSK Vaccines and one of the world’s largest companies, GE, the technological shift is an exciting development: “I’m passionate about the digital transformation that our industry is going through,” he says.

Vaccines 52

Vaccines Process Improvement Communication 52

Fuld

OCTOBER 28, 2024

” Jeff Cruz Looking ahead, AI will likely evolve into niche applications that address specific stages of the M&A process, improving efficiency while maintaining the need for human expertise in more strategic areas. This is something firms will need to navigate carefully.”

Process Improvement 52

Process Improvement 52